About this trial
Diabetic ketoacidosis (DKA) is a severe metabolic complication in children with newly diagnosed type 1 diabetes mellitus (T1DM) and may be associated with early injury of vital organs such as the kidneys and the heart. Early detection of organ dysfunction is important for identifying children at increased risk for complications.
This observational cross-sectional study aims to evaluate biomarkers of acute organ injury and associated clinical and echocardiographic parameters in children with newly diagnosed T1DM presenting with DKA, compared with children with newly diagnosed T1DM without DKA and healthy controls. Biomarkers including KIM-1, NGAL, high-sensitivity troponin, NT-proBNP, interleukin-6, and C-reactive protein will be measured during hospital admission and within the first 24-48 hours of hospitalization.
Eligibility criteria
Qualifiers
Children aged 2-16 years
Newly diagnosed type 1 diabetes mellitus
Hospital admission for initial evaluation and treatment
Presence or absence of diabetic ketoacidosis at diagnosis
Disqualifiers
Previous diagnosis of diabetes mellitus
Known chronic kidney disease
Known cardiovascular disease
Acute infection or inflammatory condition unrelated to diabetes
Trial design
Treatments tested in this trial
- Biomarker and Echocardiographic Assessment